page | |
EDITORIALS |
1016 | Is the e-cigarette harmless among asthmatic patients?
|
1019 | Patients with idiopathic pulmonary fibrosis: Overcoming 'geographic isolation'
|
1021 | Natriuretic peptides in pleural effusions: Beyond a diagnosis of heart failure
|
1023 | Three challenges of partial anomalous pulmonary venous drainage associated with pulmonary hypertension
|
1025 | Automated ventilator technology: Some answers and more questions
Simon A Joosten MBBS, BMedSc, PhD; Shane A Landry PhD; Garun S Hamilton MBBS, PhD
10.1111/resp.13802 |
COMMENTARIES |
1027 | Outnumbered yet needed: The Lung Cancer Nurse Specialist
Sara McLaughlin-Barrett BNursing, PostGrad Cert Caring for Lung Cancer Patients
10.1111/resp.13844 |
1029 | Artificial intelligence as an emerging diagnostic approach in paediatric pulmonology
Giuliana Ferrante MD, PhD; Amelia Licari MD; Gian Luigi Marseglia MD; Stefania La Grutta MD, PhD
10.1111/resp.13842 |
1031 | The generalizability of randomized controlled trials investigating non-invasive ventilation in patients with COPD
Kathryn Le Grice MBBS, BSc; Neeraj M Shah MBBS, BSc; Catey Bunce BSc (Hons), MSc, DSc; Eui-Sik Suh MBBS, MSc, PhD
10.1111/resp.13849 |
1033 | Medical ethics in the era of COVID-19: Now and the future
Christopher Chew MBBS (Hons), BMedSc (Hons), MBioethics; Danielle Ko LLB (Hons), BA, MBBS (Hons), FRACGP, FAChPM
10.1111/resp.13927 |
1035 | Ethical challenges posed by COVID-19
|
ORIGINAL ARTICLES |
Asthma and Allergy |
1037 |
Acute effects of e-cigarette vaping on pulmonary function and airway inflammation in healthy individuals and in patients with asthma
Serafeim-Chrysovalantis Kotoulas, Athanasia Pataka, Kalliopi Domvri, Dionisios Spyratos, Paraskevi Katsaounou, Konstantinos Porpodis, Evangelia Fouka, Aikaterini Markopoulou, Katalin Passa-Fekete, Ioanna Grigoriou, Theodoros Kontakiotis, Paraskevi Argyropoulou, Despoina Papakosta
10.1111/resp.13806
The e-cigarette is rapidly gaining ground on tobacco cigarettes and is a hot topic worldwide, but its safety has not been scientifically proved. This is the first study that investigates the acute effects of e-cigarettes on both lung function and airway inflammation in asthmatic patients.
|
Interstitial Lung Disease |
1046 | Pleuroparenchymal fibroelastosis in patients with idiopathic pulmonary fibrosis
Song-I Lee, Eun Jin Chae, Joon Seon Song, Jae Ha Lee, Jin Woo Song
10.1111/resp.13796
Radiological PPFE was identified in 6.3% of patients with IPF. Radiological PPFE was associated with low BMI and lung function at baseline, more frequent pneumothorax and pneumomediastinum, higher decline rates in lung function and poorer prognosis during follow-up in patients with IPF. |
1053 |
Peer Connect Service for people with pulmonary fibrosis in Australia: Participants' experiences and process evaluation
Gabriella Tikellis, Joanna Y T Lee, Tamera J Corte, Jamie Maloney, Michael Bartlett, Tonia Crawford, Ian N Glaspole, Nicole Goh, Kelcie Herrmann, Alison J Hey-Cunningham, Greg Keir, Yet H Khor, John Price, Debra G Sandford, Lissa Spencer, Alan Teoh, Jennifer Walsh, Susanne Webster, Anne E Holland
10.1111/resp.13807
The Peer Connect Service initiated by Lung Foundation Australia provides a model of support for people with a rare disease such as pulmonary fibrosis (PF) who are widely dispersed geographically. The service provides a unique opportunity for people with PF to connect and share experiences and offer mutual support.
|
Lung Cancer |
1060 | Malignant mesothelioma cells secrete natriuretic peptides: Data and diagnostic clinical implications
Vasiliki Tsolaki, Sotirios Zarogiannis, Paris Zygoulis, Ioannis Kalomenidis, Rajesh Jagirdar, Demosthenes Makris, Zoe Daniil, Sofia Magkouta, Ioannis Triantafyllou, John Papanikolaou, Konstantinos I Gourgoulianis, Epaminondas Zakynthinos
10.1111/resp.13788
BNP measured in the supernatant of malignant mesothelioma cell lines was significantly higher compared to the benign cells, denoting that BNP is secreted from these cells. Furthermore, the pleural fluid to blood BNP ratio was higher in patients with malignant mesothelioma compared to patients without malignant mesothelioma. |
Pulmonary Vascular Disease |
1066 | Partial anomalous pulmonary venous drainage in patients presenting with suspected pulmonary hypertension: A series of 90 patients from the ASPIRE registry
Robert A Lewis, Catherine G Billings, Aidan Bolger, Sarah Bowater, Athanasios Charalampopoulos, Paul Clift, Charlie A Elliot, Kate English, Neil Hamilton, Catherine Hill, Judith Hurdman, Petra J Jenkins, Christopher Johns, Simon MacDonald, James Oliver, Vasilios Papaioannou, Smitha Rajaram, Ian Sabroe, Andy J Swift, A A Roger Thompson, David G Kiely, Robin Condliffe
10.1111/resp.13815
PAPVD was frequently missed in patients presenting with suspected PH. L-R shunt was higher in patients with associated ASD. Although patients may have other potential causes of PH, some patients with PAH have isolated PAPVD without other causative conditions. |
Sleep and Ventilation |
1073 | AVAPS-AE versus ST mode: A randomized controlled trial in patients with obesity hypoventilation syndrome
Maxime Patout, Frédéric Gagnadoux, Claudio Rabec, Wojciech Trzepizur, Marjolaine Georges, Christophe Perrin, Renaud Tamisier, Jean-Louis Pépin, Claudia Llontop, Valerie Attali, Frederic Goutorbe, Sandrine Pontier-Marchandise, Pierre Cervantes, Vanessa Bironneau, Adriana Portmann, Jacqueline Delrieu, Antoine Cuvelier, Jean-François Muir
10.1111/resp.13784
Automated expiratory positive airway pressure (EPAP) and volume-targeted non-invasive ventilation achieve similar control of sleep-disordered breathing as pressure support ventilation in patients with obesity hypoventilation syndrome. Objective sleep quality at 2 months of ventilation therapy is not altered by the use of automated EPAP and volume-targeted ventilation compared to pressure support ventilation. |
POSITION STATEMENT |
1082 | Electronic cigarettes: A position statement from the Thoracic Society of Australia and New Zealand*
Christine F McDonald, Stuart Jones, Lutz Beckert, Billie Bonevski, Tanya Buchanan, Jack Bozier, Kristin V Carson-Chahhoud, David G Chapman, Claudia C Dobler, Juliet M Foster, Paul Hamor, Sandra Hodge, Peter W Holmes, Alexander N Larcombe, Henry M Marshall, Gabrielle B McCallum, Alistair Miller, Philip Pattemore, Robert Roseby, Hayley V See, Emily Stone, Bruce R Thompson, Miranda P Ween, Matthew J Peters
10.1111/resp.13904 |
FORUM AND DEBATE |
Scientific Letter |
1090 | Tocilizumab therapy in individuals with COVID-19 infection and hyperinflammatory state
Cormac McCarthy, Stefano Savinelli, Eoin R Feeney, Marcus W Butler, Cathal O'Broin, Silke Ryan, Lorraine O'Neill, David J Murphy, Charles G Gallagher, Edward F McKone, Sarmad Waqas, Aoife Cotter, Peter Doran, Michael P Keane, Patrick W Mallon
10.1111/resp.13912 |
1095 | Non-intubated electromagnetic-guided localization and resection of small indeterminate peripheral pulmonary nodules
Po-Kuei Hsu MD, PhD; Lin-Chi Chuang BS; Chien-Kun Ting PhD; Mei-Yung Tsou MD
10.1111/resp.13819 |
1096 | Non-intubated electromagnetic-guided localization and resection of small indeterminate peripheral pulmonary nodules – Reply
|
1097 | Flexible bronchoscopy-guided placement of self-expandable metallic stent for central airway obstruction-should preferably be the path less travelled!
Irfan Ismail Ayub MD, DM; Abdul Majeed Arshad MD; Sindhura Koganti MD; Dhanasekar Thangaswamy DNB
10.1111/resp.13853 |
1098 | Reply
|
LETTER FROM ASIA-PACIFIC AND BEYOND |
1099 | Letter from Italy
|
1101 | Letter from Singapore: The clinical and research response to COVID-19
|